Skip to main content
BIR Issuancesby BetterGov.phBeta
Official source
Browse issuances
Revenue Memorandum Circular · RMC

RMC No. 83-2022

To publish the May 18, 2022 letter of the Food and Drug Administration OIC-Director General endorsing updates to the List of VAT-Exempt Medicines under Republic Act No. 11534 (CREATE Act).

Bureau of Internal RevenueIndependent research copy
Document type
RMC
Number
83
Year
2022
Text quality
Not specified

Document text

Reference copy · verify against the official source
RMC No. 83-2022, issued June 30, 2022, publishes a May 18, 2022 letter from FDA OIC-Director General Dr. Oscar G. Gutierrez, Jr. endorsing updates to the List of VAT-Exempt Medicines under Republic Act No. 11534 (CREATE Act). The updates add certain medicines for diabetes, hypertension and mental illnesses, delete certain medicines for cancer and kidney diseases, and correct the Dosage Form of a medicine for kidney diseases. The excerpt summarizes the changes but does not reproduce the actual list of medicines.